Knight Therapeutics | Bruttoavancen På Salg



Gross Profit On Sales Lave om Dato
Alaunos Therapeutics -1127000 1.11M 2024-09
Aurora Cannabis CAD 9.35M 6.18M 2024-12
Avita Medical AUD 16.13M 3.05M 2024-12
Canopy Growth CAD 24.1M 2.26M 2024-12
Cronos Group USD 10.81M 7.2M 2024-12
Ionis Pharmaceuticals USD 222.75M 90M 2024-12
IQVIA Holdings USD 1.38B 0 2024-12
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Moderna USD 420M 1.14B 2024-12
Organigram Holdings CAD 1.05M 67.34M 2024-12
Organon & Co USD 896M 27M 2024-12
Revvity USD 412.29M 27.47M 2024-12
Tilray USD 61.22M 1.51M 2024-11
Viatris USD 1.39B 211M 2024-12
Xeris Pharmaceuticals USD 40.67M 400K 2024-09



Knight Therapeutics Bruttoavancen På Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.